Market Overview:
The global HMOs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for HMOs from the food industry and laboratory research applications. The neutral HMOs segment is expected to dominate the global market, followed by acidic HMOs, during the forecast period. North America is expected to lead the global market in terms of revenue, followed by Europe and Asia Pacific.
Product Definition:
An HMO is a healthcare organization that provides comprehensive care to its members through a network of contracted physicians. An important benefit of HMOs is that they offer preventive care services at no additional cost to their members.
Neutral HMOs:
Neutral HMOs are used to treat tooth decay, gum diseases and oral cancer. They are also known as non-toxic HMO or N-HMO. It is a group of chemical substances that can enter cells and damage their reproductive ability. This chemical is considered safe for consumption by the FDA (Food & Drug Administration) because it does not have any side effects on human health when consumed in prescribed limits.
Acidic HMOs:
Acidic HMOs are highly soluble in water and have a pH value below 7.5. They are used as an additive to increase the solubility of hydrophobic hydroxyapatite (HAP) in organic solvents, thus enabling its application as an adsorbent for metal ions. Acidic HMOs can be manufactured by chemical synthesis or biotechnology methods; both techniques produce similar results with respect to product yield and cost involved.
Application Insights:
The food industry accounted for the largest revenue share in 2016. The segment is expected to continue its dominance over the forecast period owing to factors such as increasing consumer demand for cost-efficient and high-quality products, growing influence of retail distribution channels on purchasing decisions, and rising importance of brand image in the market.
Neutral HMOs are majorly used by food processing industries as they offer a wide range of benefits including economies of scale, improved operational efficiency due to centralized purchasing power, reduced inventory levels resulting in lower storage costs and space requirements at a corporate level. However, acidic HMOs have been witnessing increased adoption by this industry on account of their ability to control costs while maintaining quality standards imposed by regulatory authorities. Increasing R&D activities pertaining to new product development coupled with stringent regulations regarding safety & hygiene at global level are anticipated to further drive growth over next eight years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to various factors such as increasing geriatric population, rising healthcare expenditure, and growing adoption of technologically advanced products by end-users. Moreover, presence of a large number of players in this region is also likely to contribute toward regional growth over the next eight years.
Asia Pacific HMOs market is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and economic development coupled with high demand for laboratory research services from pharmaceutical companies based in Japan and China for drug discovery purposes. In addition, increasing outsourcing activities by developed countries are also contributing toward regional growth through their supply chains across Asia Pacific region which includes India & China regions (excluding Hong Kong).
Growth Factors:
- Increasing demand for healthcare services due to population growth and aging population.
- Rising awareness about the benefits of preventive care and early diagnosis.
- Growing preference for managed care plans among consumers, especially in the wake of rising healthcare costs.
- Proliferation of digital health technologies that facilitate remote monitoring and treatment of patients.
Scope Of The Report
Report Attributes
Report Details
Report Title
HMOs Market Research Report
By Type
Neutral HMOs, Acidic HMOs
By Application
Food Industry, Laboratory Research
By Companies
Abbott, Inbiose, Jennewein Biotechnologie, Glycom, ZuChem, Dextra Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
198
Number of Tables & Figures
139
Customization Available
Yes, the report can be customized as per your need.
Global HMOs Market Report Segments:
The global HMOs market is segmented on the basis of:
Types
Neutral HMOs, Acidic HMOs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food Industry, Laboratory Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Inbiose
- Jennewein Biotechnologie
- Glycom
- ZuChem
- Dextra Laboratories
Highlights of The HMOs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Neutral HMOs
- Acidic HMOs
- By Application:
- Food Industry
- Laboratory Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HMOs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HMOs are health maintenance organizations. They provide a variety of services, including medical care, prescription drugs, and mental health services.
Some of the major players in the hmos market are Abbott, Inbiose, Jennewein Biotechnologie, Glycom, ZuChem, Dextra Laboratories.
The hmos market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HMOs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HMOs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HMOs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HMOs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HMOs Market Size & Forecast, 2020-2028
4.5.1 HMOs Market Size and Y-o-Y Growth
4.5.2 HMOs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Neutral HMOs
5.2.2 Acidic HMOs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Food Industry
6.2.2 Laboratory Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HMOs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HMOs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Neutral HMOs
9.6.2 Acidic HMOs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Food Industry
9.10.2 Laboratory Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Neutral HMOs
10.6.2 Acidic HMOs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Food Industry
10.10.2 Laboratory Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Neutral HMOs
11.6.2 Acidic HMOs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Food Industry
11.10.2 Laboratory Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Neutral HMOs
12.6.2 Acidic HMOs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Food Industry
12.10.2 Laboratory Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Neutral HMOs
13.6.2 Acidic HMOs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Food Industry
13.10.2 Laboratory Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HMOs Market: Competitive Dashboard
14.2 Global HMOs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Inbiose
14.3.3 Jennewein Biotechnologie
14.3.4 Glycom
14.3.5 ZuChem
14.3.6 Dextra Laboratories
